Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 9NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 8Neuroblastoma 8Carcinoma, Ovarian Epithelial 6Uterine Cervical Neoplasms 4Fallopian Tube Neoplasms 4Sarcoma 3Leukemia 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Brenner Tumor 2Brain Neoplasms 2Wilms Tumor 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Pleuropulmonary blastoma 1Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Meningeal Carcinomatosis 1Medulloblastoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1

Interventions

Temozolomide 11Radiotherapy 6Lomustine 3Vincristine 2Procarbazine 2Carmustine 2veliparib 1trametinib 1selinexor 1ribociclib 1lonafarnib 1dabrafenib 1carmustine, poliferprosan 20 drug combination 1Watchful Waiting 1Topotecan 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Psychiatric Rehabilitation 1Platelet Count 1Panobinostat 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1Hydroxychloroquine 1Everolimus 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Glioma × Topotecan × Clear all
NCT00003372 2020-04-08

Topotecan in Treating Patients With Recurrent Brain Tumors

Canadian Cancer Trials Group

Phase 2 Completed
17 enrolled
CNS

Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡